Microvolt T-wave alternans testing provides a reliable means of guiding anti-arrhythmic therapy
Gupta et al1 present a meta-analysis and conclude that microvolt T-wave alternans testing (MTWA) does not modify risk of sudden cardiac death (SCD) sufficiently for clinical use. Their analysis involves a number of methodological limitations. The authors included in their primary analysis numerous s...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | en_US |
| Published: |
Elsevier B.V.
2013
|
| Online Access: | http://hdl.handle.net/1721.1/79792 https://orcid.org/0000-0002-5573-0137 |